STING
National service evaluation of MSK steroid injection
Update 09/11/2020
- We recruiting units to collect data for the project.
A significant clinical question during the pandemic is the safety of steroid use.
As communicated by Little et al (1), removing steroid injections as a legitimate treatment option for a large cohort of patients does not seem a measured or responsible option.
This prospective service evaluation aims to quantify risk associated with any musculo-skeletal steroid injection during the pandemic.
Collaborators will be asked to input information on patient demographics, background Covid risk and steroid injection specifics. At follow up and at 4-6 weeks complications and Covid specific outcomes will be recorded.
Yellow card reporting and Covid consent process is also reported. In this way clinicians can be safe that they are monitoring outcomes appropriately, in line with national guidance, and that in due course information on local steroid safety will be available.
Register here to become a collaborator on the study.
Get involved
We are currently recruiting collaborators.
There is no issue with having several collaborators from one unit in this project.
Responsibilities of a collaborator to be PubMed cited
- Gain support from your department (e.g. consultant supervisor)
- Register the study with your NHS Trust.
- Collect prospective data on steroid injections during the data collection window.
- Upload anonymised data to the REDCap database.
Benefits
- Certificate of involvement will be provided on completion of the project.
- Pubmed citation on any subsequent publication directly related to these data.
- Cited as a collaborator on any presentation relating to these data and RSTN website.
- Option to present local data separately (i.e. local or regional meeting).
Salma Elamin
Grey Giddins
Emma Reay